MTOR and hepatocellular carcinoma: Recent evidence has shown that the mTOR pathway is expressed at a higher level in HCC cells, and tumor regression was achieved in HCC-harboring animals by treatment with rapamycin (Lee et al., 2020a; Chao et al., 2020; Ferrin et al., 2020).